trending Market Intelligence /marketintelligence/en/news-insights/trending/dXYyt9KajVyv5JnpHkSzAA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Actinium Pharmaceuticals appoints chief medical officer

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Actinium Pharmaceuticals appoints chief medical officer

Actinium Pharmaceuticals Inc. tapped Mark Berger to replace Dragan Cicic as the company's chief medical officer.

Cicic was appointed to the newly created position of chief technology officer at the company.

Berger joins Actinium from Kadmon Corp., where he was senior vice president of clinical research.